CRNA.OL Circio Holding ASA

Healthcare Biotechnology Oslo Stock Exchange
10.00 NOK
Close of Nov 3, 2026
0.9100 15.70
Market cap
NOK 2.91B
P/E
-
P/B
5.55x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is CRNA.OL undervalued?

Graham number

The Graham number of Circio Holding ASA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Circio Holding ASA fundamental analysis

No fundamental analysis for Circio Holding ASA yet.

Circio Holding ASA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a research collaboration with United Immunity Co., Ltd. for th…

Full company profile